11月24日，英科医疗涨5%，截至发稿，报40.50元/股，成交2.67亿元，换手率1.43%，总市值265.19亿 元。 资料显示，英科医疗科技股份有限公司位于山东省淄博市临淄区齐鲁化学工业园清田路18号,香港湾仔 皇后大道东248号阳光中心40楼，成立日期2009年7月20日，上市日期2017年7月21日，公司主营业务涉 及涵盖个人防护、康复护理、其他产品三大板块。主营业务收入构成为：个人防护类91.47%，康复护 理类4.75%，其他产品3.77%。 从基金十大重仓股角度 责任编辑：小浪快报 富国中证医药主题指数增强型(LOF)A（161035）基金经理为牛志冬、蔡卡尔。 截至发稿，牛志冬累计任职时间10年199天，现任基金资产总规模248.49亿元，任职期间最佳基金回报 111.51%， 任职期间最差基金回报-88.81%。 蔡卡尔累计任职时间8年325天，现任基金资产总规模1118.94亿元，任职期间最佳基金回报51.06%， 任 职期间最差基金回报-32.1%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何 ...

Core Viewpoint - Inco Medical experienced a decline of 5.05% in its stock price, reaching 37.42 CNY per share, with a trading volume of 321 million CNY and a turnover rate of 1.81%, resulting in a total market capitalization of 24.502 billion CNY [1] Company Overview - Inco Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017 [1] - The company's main business segments include personal protection, rehabilitation care, and other products, with revenue composition as follows: personal protection 91.47%, rehabilitation care 4.75%, and other products 3.77% [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Caitong Fund has a significant position in Inco Medical [2] - Caitong Medical Health Mixed A Fund (018937) held 95,200 shares in the third quarter, accounting for 5.97% of the fund's net value, making it the second-largest holding [2] - The fund has experienced a floating loss of approximately 189,400 CNY today [2] Fund Performance - Caitong Medical Health Mixed A Fund (018937) was established on March 27, 2024, with a latest scale of 50.4705 million CNY [2] - Year-to-date return is 14.86%, ranking 5206 out of 8213 in its category; the one-year return is 13.41%, ranking 5016 out of 8130; and since inception, the return is 14.15% [2] - The fund manager, Luo Ying, has a tenure of 4 years and 130 days, with total assets under management of 58.5742 million CNY [2]

Core Viewpoint - Inke Medical's stock price has shown significant growth this year, with a year-to-date increase of 64.94%, reflecting strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Inke Medical reported a revenue of 7.425 billion yuan, representing a year-on-year growth of 4.60% [2]. - The net profit attributable to shareholders for the same period was 924 million yuan, marking a substantial increase of 34.47% compared to the previous year [2]. Stock Market Activity - As of November 12, Inke Medical's stock price reached 41.45 yuan per share, with a trading volume of 230 million yuan and a market capitalization of 27.141 billion yuan [1]. - The stock experienced a net inflow of 15.9098 million yuan from institutional investors, indicating positive sentiment [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Inke Medical decreased by 21.11% to 47,300, while the average number of shares held per shareholder increased by 25.65% to 9,832 shares [2][4]. - The top circulating shareholders include various ETFs and mutual funds, with notable changes in holdings among major investors [4]. Dividend Distribution - Inke Medical has distributed a total of 1.903 billion yuan in dividends since its A-share listing, with 245 million yuan distributed over the past three years [3].

Core Viewpoint - In recent trading, Yingke Medical's stock price has shown a decline of 2.02%, with a current price of 38.36 CNY per share and a total market capitalization of 25.118 billion CNY. The company has experienced a year-to-date stock price increase of 52.64% [1] Financial Performance - For the period from January to September 2025, Yingke Medical reported a revenue of 7.425 billion CNY, reflecting a year-on-year growth of 4.60%. The net profit attributable to shareholders was 924 million CNY, marking a significant increase of 34.47% compared to the previous year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Yingke Medical decreased by 21.11% to 47,300. The average number of circulating shares per shareholder increased by 25.65% to 9,832 shares [2] Dividend Distribution - Yingke Medical has cumulatively distributed dividends amounting to 1.903 billion CNY since its A-share listing, with a total of 245 million CNY distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders of Yingke Medical include notable ETFs such as Huabao Zhongzheng Medical ETF and Yifangda Growth Enterprise Board ETF, with some shareholders reducing their holdings while others have newly entered [4]

Group 1 - The core viewpoint of the news is that Yingke Medical's stock has increased by 5.01%, reaching a price of 42.13 CNY per share, with a trading volume of 565 million CNY and a turnover rate of 2.95%, resulting in a total market capitalization of 27.586 billion CNY [1] - Yingke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017. The company operates in three main business segments: personal protection, rehabilitation care, and other products [1] - The revenue composition of Yingke Medical is as follows: personal protection accounts for 91.47%, rehabilitation care for 4.75%, and other products for 3.77% [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under Southern Fund ranks among the top shareholders of Yingke Medical. The Southern CSI 500 ETF (510500) increased its holdings by 967,200 shares in the second quarter, bringing its total to 6.698 million shares, which represents 1.43% of the circulating shares [2] - The estimated floating profit for the Southern CSI 500 ETF today is approximately 13.4629 million CNY [2] - The Southern CSI 500 ETF was established on February 6, 2013, with a latest scale of 113.438 billion CNY. Year-to-date returns are 28.62%, ranking 1823 out of 4219 in its category, while the one-year return is 28.52%, ranking 1678 out of 3877 [2]

Group 1 - The core point of the news is that Yingke Medical's stock price increased by 5.01% to 42.13 CNY per share, with a trading volume of 566 million CNY and a turnover rate of 2.96%, resulting in a total market capitalization of 27.586 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - According to data from fund holdings, one fund under Zheshang Securities Asset Management heavily invests in Yingke Medical, with Zheshang Huijin Quantitative Selected Stocks A (011824) holding 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has achieved a year-to-date return of 27.54%, ranking 1932 out of 4219 in its category, and a one-year return of 32.66%, ranking 1391 out of 3877 [2] Group 3 - The fund manager of Zheshang Huijin Quantitative Selected Stocks A is Chen Gujun, who has been in the position for 5 years and 282 days, with the fund's total asset size at 204 million CNY [3] - During Chen Gujun's tenure, the best fund return was 38.13%, while the worst was -7.57% [3]

Group 1 - In October 17, 2023, Yingke Medical experienced a decline of 5.05%, with a stock price of 43.20 yuan per share, a trading volume of 1.434 billion yuan, a turnover rate of 6.69%, and a total market capitalization of 28.287 billion yuan [1] - Yingke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017. The company's main business includes three segments: personal protection, rehabilitation care, and other products [1] - The revenue composition of Yingke Medical is as follows: personal protection accounts for 91.47%, rehabilitation care for 4.75%, and other products for 3.77% [1] Group 2 - From the perspective of the top ten holdings of funds, one fund under Zheshang Securities Asset Management has a significant position in Yingke Medical. The Zheshang Huijin Quantitative Selected Stock A (011824) held 40,200 shares in the second quarter, representing 0.75% of the fund's net value, making it the second-largest holding [2] - The estimated floating loss for the fund on the current day is approximately 92,500 yuan. The Zheshang Huijin Quantitative Selected Stock A (011824) was established on July 1, 2021, with a latest scale of 63.808 million yuan. Year-to-date, it has achieved a return of 28.41%, ranking 1771 out of 4218 in its category; over the past year, it has returned 38.96%, ranking 1351 out of 3865; and since inception, it has returned 18.1% [2] Group 3 - The fund manager of Zheshang Huijin Quantitative Selected Stock A (011824) is Chen Gujun, who has been in the position for 5 years and 272 days. The total asset size of the fund is 204 million yuan, with the best fund return during his tenure being 40.06% and the worst being -7.57% [3]

Core Insights - Inke Medical experienced a 5.05% increase in stock price, reaching 44.97 yuan per share, with a trading volume of 818 million yuan and a turnover rate of 4.08%, resulting in a total market capitalization of 29.446 billion yuan [1] Company Overview - Inke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017 [1] - The company's main business segments include personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Fund Holdings - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Inke Medical, specifically the Zhejiang Merchants Huijin Quantitative Selected Stock A (011824), which held 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has generated a floating profit of approximately 86,800 yuan as of the report date [2] Fund Performance - The Zhejiang Merchants Huijin Quantitative Selected Stock A fund was established on July 1, 2021, with a current size of 63.808 million yuan [2] - Year-to-date, the fund has achieved a return of 29.32%, ranking 1753 out of 4218 in its category, while its one-year return stands at 39.78%, ranking 1330 out of 3864 [2]

Group 1 - The core point of the news is that Yingke Medical's stock price increased by 5.05% to 44.97 CNY per share, with a trading volume of 8.11 billion CNY and a turnover rate of 4.04%, resulting in a total market capitalization of 294.46 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - Among the top ten circulating shareholders of Yingke Medical, E Fund's Chuangye ETF (159915) reduced its holdings by 272,900 shares in the second quarter, now holding 10.6244 million shares, which accounts for 2.26% of circulating shares [2] - The E Fund Chuangye ETF (159915) was established on September 20, 2011, with a latest scale of 85.537 billion CNY, achieving a year-to-date return of 43.03% and a one-year return of 46.72% [2] Group 3 - The fund managers of E Fund Chuangye ETF are Cheng Xi and Liu Shurong, with Cheng having a tenure of 9 years and 165 days and a total fund size of 195.312 billion CNY, while Liu has a tenure of 8 years and 93 days with a fund size of 112.299 billion CNY [3]

Group 1 - The core point of the news is that Yingke Medical's stock price increased by 5.23% to 38.62 CNY per share, with a trading volume of 391 million CNY and a turnover rate of 2.25%, resulting in a total market capitalization of 25.288 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - Dachen Fund has a significant holding in Yingke Medical, with its Dachen Growth Mixed Fund (160926) increasing its stake by 120,000 shares in the second quarter, bringing the total to 848,900 shares, which accounts for 3.37% of the fund's net value [2] - The Dachen Growth Mixed Fund has a current size of 449 million CNY and has achieved a year-to-date return of 26.47%, ranking 4062 out of 8166 in its category [2] Group 3 - The fund manager of Dachen Growth Mixed Fund is Zou Jian, who has been in the position for 4 years and 259 days, managing a total asset size of 1.086 billion CNY [3] - During Zou Jian's tenure, the best fund return was 12.49%, while the worst return was -21.29% [3]